Ozempic
Every GLP-1 the FDA has approved, and the active ingredient inside each one.
What is Ozempic?
Semaglutide sold as a weekly injection for type 2 diabetes at 0.5, 1 and 2 mg.
Chemically identical to Wegovy, approved for a different job, and prescribed off-label for weight loss constantly. The brand name turns up in advertising far more often than in the vial.
GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature.
Where Ozempic comes up on this site
On GLP Watchdog, Ozempic comes up in 6 research articles, 60 seller reviews, 10 FDA warning letters and 4 tools. Browse the FDA warning letters.
Research that discusses it
- Compounded Semaglutide vs Ozempic and Wegovy: What Is Actually Different
- Does Medicaid Cover Ozempic and Wegovy? Same Molecule, Different Answers
- Joint Pain, Back Pain and Aches on a GLP-1: What the Trials Counted
- Stomach Pain on a GLP-1: What Is Expected and What Is a Warning Sign
- Is Zepbound a Semaglutide? Brand Names vs Molecules
- GLP-1s and Hormonal Birth Control: Which Labels Carry the Warning
Drug pages
Tools that use it
Seller reviews that mention it
Other terms under Drugs and brands
Where the evidence lives
- Ozempic drug page
- The full GLP-1 glossary (149 terms, 8 categories)
- Research articles — written from primary sources
- Tools and calculators
- Compare GLP-1 telehealth providers